Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
BD Invests $110 Million to Expand U.S. Biologic Drug Supply Chain
BD Becton, Dickinson and Company is investing $110 million to expand production of prefillable syringes at its Columbus, Nebraska site The investment aims to strengthen the US pharmaceutical supply chain, support reshoring of drug manufacturing
Sharp Services Invests Over €20 Million to Expand European Injectable Packaging
Sharp Services has announced a major investment of more than 20 million to expand its European facilities for injectable drug packaging The move responds to growing demand for complex injectable formats and aims to increase production
Samsung Biologics Expands U.S. Manufacturing with $280 Million Acquisition of Human Genome Sciences
Samsung Biologics has announced the acquisition of Human Genome Sciences from GSK, marking its first USbased manufacturing site The Rockville, Maryland facility will expand the companys global manufacturing
INCOG BioPharma Plans Major $200 Million Facility Expansion in Indiana
INCOG BioPharma Services has announced a major $200 million expansion of its injectable drug manufacturing facility in Fishers, Indiana The investment will significantly increase production capacity and support longterm growth, positioning the site as a leading global hub for injectable biopharmaceutical manufacturing
AstraZeneca Expands U.S. Manufacturing Capacity with $2B Maryland Investment
AstraZeneca has announced plans to invest $2 Billion in expanding its manufacturing operations in Maryland, strengthening its presence in one of the United States leading life sciences regions
Moderna Expands U.S. Manufacturing Capabilities with $140M Investment
Moderna, Inc is expanding its US manufacturing capabilities by onshoring Drug Product production to its Moderna Technology Center MTC in Norwood, Massachusetts This development completes the companys
Eli Lilly to Expand European Footprint with $3B Oral Medicines Plant in Netherlands
Eli Lilly and Company plans to invest $3 billion in a new manufacturing facility in Katwijk, located within the Leiden Bio Science Park in the Netherlands
Eli Lilly Invests $1.2 Billion to Boost Oral Drug Production in Puerto Rico
Eli Lilly and Company has announced plans to invest more than $12 billion to expand and modernise its Lilly del Caribe manufacturing facility in Carolina, Puerto Rico The investment aims to strengthen the companys production
Merck Breaks Ground on $3 Billion Pharmaceutical Manufacturing Center in Virginia
Merck has started construction on a $3 billion Centre of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia The 400,000squarefoot facility is part of Mercks longterm plan to expand domestic
AstraZeneca Announces $4.5B Investment in Virginia Production Facility
AstraZeneca has announced a $45 billion investment in its new manufacturing facility at Rivanna Futures in Albemarle County, Virginia
